Table 4.
Diabetes (n = 476) | No Diabetes (n = 2012) | P Value | |
---|---|---|---|
Receiving any prophylaxis, n (%) | 253 (60.4) | 774 (46.6) | <.001 |
Pneumatic compression devices, n (%) | 134 (32.0) | 430 (25.9) | .01 |
Subcutaneous unfractionated heparin, n (%) | 129 (30.8) | 325 (19.6) | <.001 |
Low-molecular-weight heparin, n (%) | 47 (11.2) | 141 (8.5) | .09 |
Intravenous unfractionated heparin, n (%) | 41 (9.8) | 87 (5.2) | .001 |
Warfarin, n (%) | 24 (5.7) | 75 (4.5) | .31 |
Patients could have received >1 prophylactic modality.